Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06316934 · ClinicalTrials.gov registry record · Phase 2
Lavender Aromatherapy to Decrease Anxiety/Pain Perception During Office Hysteroscopy
A Phase 2 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT06316934 is a Phase 2 study that was terminated before completion, run by University of Florida. The registered enrollment target is 22 participants.
The verdict
NCT06316934, a Phase 2 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
Office hysteroscopy is an invaluable practice to treat a myriad of gynecological processes. However, a limiting factor is the perceived pain and anxiety. In a randomized pilot study, treatment with lavender aromatherapy will significantly decrease the stress/anxiety levels associated with office hysteroscopy, as measured on a visual analogue scale and the Hospital Anxiety and Depression Scale (HADS) questionnaire when compared to control subjects receiving distilled water placebo.
Interventions
- OTHER Placebo
- DRUG Lavandula angustifolia, Aura Cacia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2025-04-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06316934
The ClinicalTrials.gov registry entry for NCT06316934 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06316934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06316934 about?
NCT06316934 is a clinical study titled "Lavender Aromatherapy to Decrease Anxiety/Pain Perception During Office Hysteroscopy". Office hysteroscopy is an invaluable practice to treat a myriad of gynecological processes. However, a limiting factor is the perceived pain and anxiety. In a randomized pilot study, treatment with lavender aromatherapy will significantly decrease the stress/anxiety levels associated with office hys...
What is the current status of trial NCT06316934?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2024-06-01. Estimated completion is 2025-04-21.
What interventions are being tested in trial NCT06316934?
The interventions under investigation include: Placebo (OTHER), Lavandula angustifolia, Aura Cacia (DRUG).
Who is sponsoring clinical trial NCT06316934?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.